4.3 Article

Serum growth differentiation factor 15 is closely associated with metabolic abnormalities in Chinese pregnant women

期刊

JOURNAL OF DIABETES INVESTIGATION
卷 12, 期 8, 页码 1501-1507

出版社

WILEY
DOI: 10.1111/jdi.13488

关键词

Gestational diabetes; Growth differentiation factor 15; Metabolic abnormalities

资金

  1. Shanghai Municipal Health Commission, China [202040182]

向作者/读者索取更多资源

The study aimed to investigate the relationship between serum growth differentiation factor 15 (GDF15) and metabolic abnormalities in Chinese pregnant women. Results showed that serum GDF15 levels were linearly correlated with glucose metabolism indices and triglycerides. As GDF15 levels increased, the risk of metabolic abnormalities also increased, especially in cases with multiple metabolic abnormalities. The findings suggest that serum GDF15 levels could serve as a predictor for metabolic abnormalities during pregnancy.
Aims To explore the relationship between serum growth differentiation factor 15 (GDF15) and metabolic abnormalities in Chinese pregnant women. Materials and Methods We recruited 200 patients with gestational diabetes mellitus (GDM) and 211 matched normal control within 24-28 weeks of pregnancy. Enzyme-linked immunosorbent assay (ELISA) was used to determine the serum GDF15 levels of all participants. Then we grouped participants according to the number of metabolic abnormalities (including blood glucose, blood lipids and blood pressure), divided them into a normal metabolic group, one metabolic abnormality group, two or more metabolic abnormalities group. Finally, multinomial logistic regression analysis was used to estimate the odds radio (OR) and 95% CIs expressing the association between GDF15 and metabolic abnormalities in pregnant women. Results Through bivariate correlation analysis, we found that serum GDF15 is linearly correlated with glucose metabolism indices, such as 1h-PG, 2h-PG, HbA1c (all P < 0.05). In addition, serum GDF15 and triglycerides were linearly correlated (P < 0.05). Grouping by the number of metabolic abnormalities, we found that as GDF15 levels increased, the risk of metabolic abnormalities also increased (OR > 1), and the risk of multiple metabolic abnormalities was higher. As the number of metabolic abnormalities increased, serum GDF15 levels also were elevated (P < 0.001). Conclusions The results suggest that serum GDF15 levels are closely associated with metabolic abnormalities in pregnant women and may be used as a predictor of metabolic abnormalities during pregnancy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据